1. Abualhaj B, Weng GY, Ong M, Attarwala AA, Molina F, Busing K, Glatting G. Comparison of five cluster validity indices performance in brain F-18 FET-PET image segmentation using k-means. Medical Physics 2017; 44:209-220.
  2. Attarwala AA, Karanja YW, Hardiansyah D, Romano C, Roscher M, Wangler B, Glatting G. Investigation of the imaging characteristics of the ALBIRA II small animal PET system for F-18, Ga-68 and Cu-64. Zeitschrift Fur Medizinische Physik 2017; 27:132-144.
  3. Beer AJ, Dijkgraaf I. Editorial European Journal of Nuclear Medicine and Molecular Imaging. European Journal of Nuclear Medicine and Molecular Imaging 2017; 44:284-285.
  4. Eiber M, Rauscher I, Souvatzoglou M, Maurer T, Schwaiger M, Holzapfel K, Beer AJ. Prospective head-to-head comparison of C-11-choline-PET/MR and C-11-choline-PET/CT for restaging of biochemical recurrent prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 2017; 44:2179-2188.
  5. Fendler WP, Calais J, Allen-Auerbach M, Bluemel C, Eberhardt N, Emmett L, Gupta P, Hartenbach M, Hope TA, Okamoto S, Pfob CH, Pöppel TD, Rischpler C, Schwarzenböck S, Stebner V, Unterrainer M, Zacho HD, Maurer T, Gratzke C, Crispin A, Czernin J, Herrmann K, Eiber M. 68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study. J Nucl Med. 2017 Oct;58(10):1617-1623. doi: 10.2967/jnumed.117.190827. Epub 2017 Apr 13
  6. Hardiansyah D, Attarwala AA, Kletting P, Mottaghy FM, Glatting G. Prediction of time-integrated activity coefficients in PRRT using simulated dynamic PET and a pharmacokinetic model. Physica Medica-European Journal of Medical Physics 2017; 42:298-304.
  7. Hardiansyah D, Guo W, Attarwala AA, Kletting P, Mottaghy FM, Glatting G. Treatment planning in PRRT based on simulated PET data and a PBPK model. Nuklearmedizin-Nuclear Medicine 2017; 56:23-30.
  8. Hoffmann TK, Schuler PJ, Laban S, Grasslin R, Beer M, Beer AJ, Friebe-Hoffmann U, Bullinger L, Moller P, Wiegel T. Response Evaluation in Head and Neck Oncology: Definition and Prediction. Orl-Journal for Oto-Rhino-Laryngology Head and Neck Surgery 2017; 79:14-23.
  9. Kramer L, Winter G, Baur B, Kuntz AJ, Kull T, Solbach C, Beer AJ, Linden M. Quantitative and correlative biodistribution analysis of Zr-89-labeled mesoporous silica nanoparticles intravenously injected into tumor-bearing mice. Nanoscale 2017; 9:9743-9753.
  10. Krohn T, Birmes A, Winz OH, Drude NI, Mottaghy FM, Behrendt FF, Verburg FA. The reconstruction algorithm used for Ga-68 PSMA-HBED-CC PET/CT reconstruction significantly influences the number of detected lymph node metastases and coeliac ganglia. European Journal of Nuclear Medicine and Molecular Imaging 2017; 44:662-669.
  11. Maier CP, Kapp-Schwoerer S, Moeller P, Beer A, Gruener B. A rare cause of constitutional symptoms after returning from Far and Middle East: subcutaneous panniculitis-like T-cell lymphoma (SPTL). Oncology Research and Treatment 2017; 40:157-157.
  12. O'Connor JPB, Aboagye EO, Adams JE, Aerts H, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, Desouza NM, Dickson JC, Dive C, Evelhoch JL, Faivre-Finn C, Gallagher FA, Gilbert FJ, Gillies RJ, Goh V, Griffiths JR, Groves AM, Halligan S, Harris AL, Hawkes DJ, Hoekstra OS, Huang EP, Hutton BF, Jackson EF, Jayson GC, Jones A, Koh DM, Lacombe D, Lambin P, Lassau N, Leach MO, Lee TY, Leen EL, Lewis JS, Liu Y, Lythgoe MF, Manoharan P, Maxwell RJ, Miles KA, Morgan B, Morris S, Ng T, Padhani AR, Parker GJM, Partridge M, Pathak AP, Peet AC, Punwani S, Reynolds AR, Robinson SP, Shankar LK, Sharma RA, Soloviev D, Stroobants S, Sullivan DC, Taylor SA, Tofts PS, Tozer GM, van Herk M, Walker-Samuel S, Wason J, Williams KJ, Workman P, Yankeelov TE, Brindle KM, McShane LM, Jackson A, Waterton JC. Imaging biomarker roadmap for cancer studies. Nature Reviews Clinical Oncology 2017; 14:169-186.
  13. Tews D, Fischer-Posovszky P, Debatin KM, Beer AJ, Wabitsch M. Physiological relevance of brown adipose tissue in humans. Monatsschrift Kinderheilkunde 2017; 165:502-509.
  14. Trajkovic-Arsic M, Heid I, Steiger K, Gupta A, Fingerle A, Worner C, Teichmann N, Sengkwawoh-Lueong S, Wenzel P, Beer AJ, Esposito I, Braren R, Siveke JT. Apparent Diffusion Coefficient (ADC) predicts therapy response in pancreatic ductal adenocarcinoma. Scientific Reports 2017; 7:17038.
  15. Weber T, Gottstein M, Schwenzer S, Beer A, Luster M. Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas? World Journal of Surgery 2017; 41:980-985.
  16. Wieder H, Beer AJ, Holzapfel K, Henninger M, Maurer T, Schwarzenboeck S, Rummeny EJ, Eiber M, Stollfuss J. 11C-choline PET/CT and whole-body MRI including diffusion-weighted imaging for patients with recurrent prostate cancer. Oncotarget 2017; 8:66516-66527.
  17. European Association of Nuclear M, European Federation of Organizations for Medical P, European Federation of Radiographer S, European Society of R, European Society for R, Oncology. Common strategic research agenda for radiation protection in medicine. Insights Imaging 2017; 8:183-197.